Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
J. L. Pepin, R. Tamisier, G. Barone-Rochette, P. Levy, J. P. Baguet (Grenoble, France). Comparison of continuous positive airway pressure and valsartan 160 mg in hypertensive sleep apnoea patients never treated for both conditions: the VALSAS study. Eur Respir J 2009; 34: Suppl. 53, 3736

Member's Comments

No comment yet.

Related content which might interest you: Effect of automatic positive airway pressure (APAP) therapy on blood pressure (BP) in patients with obstructive sleep apnea (OSA) and hypertension Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy Year: 2008 Effect of continuous positive airway pressure treatment on hypoadiponectinemia in male patients with obstructive sleep apnea syndrome Source: Annual Congress 2005 - Metabolic control in OSA Year: 2005 Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients Source: Eur Respir J 2006; 27: 1229-1235 Year: 2006 Differential blood pressure response to continuous positive airway pressure treatment according to the circadian pattern in hypertensive patients with obstructive sleep apnoea Source: Eur Respir J, 54 (1) 1900098; 10.1183/13993003.00098-2019 Year: 2019 Evaluation of continuous positive airway pressure compliance in a group of obstructive sleep apnea patients Source: Annual Congress 2012 - Clinical predictors of OSA, adherence to CPAP and psychology Year: 2012 Nasal continuous positive airway pressure in stroke patients with sleep apnoea: a randomized treatment study Source: Eur Respir J 2001; 18: 630-634 Year: 2001 Efficacy of continuous positive airway pressure treatment to resistant hypertension in patients with obstructive sleep apnea syndrome Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy Year: 2008 Positive effect of CPAP treatment on the control of difficult-to-treat hypertension Source: Eur Respir J 2007; 29: 951-957 Year: 2007 Pressure reduction during exhalation in sleep apnea patients treated by continuous positive airway pressure (CPAP) Source: Annual Congress 2008 - Innovative treatments in sleep disordered breathing Year: 2008 Fixed-pressure CPAP versus auto-adjusting CPAP : Comparison of efficacy in obstructive sleep apnoea (OSAS) according to the individual level of efficient pressure and pressure variability. Source: International Congress 2018 – New diagnostic tools for sleep and breathing and healthcare provision options Year: 2018 Predictive factors for stopping use of continuous positive airway pressure (CPAP): an observational cohort of 6938 treated obstructive sleep apnea syndrome (OSAS) patients Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea Year: 2007 Outcomes in patients with REM-related obstructive sleep apnoea (REM-OSA) treated with continuous positive airway pressure (CPAP) Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects Year: 2019 CPAP treatment reduce blood pressure in patients with recent diagnosis of systemic hypertension and obstructive sleep apnoea -hypopnoea (OSAH). A controlled study Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy Year: 2008 The need of higher CPAP pressure in a population with obstructive sleep apnea (OSA) and refractory hypertension (RHT) versus controlled hypertension-a retrospective study Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012 Continuous positive airway pressure treatment in patients with OSA Source: Eur Respir Mon 2010; 50: 244-266 Year: 2010 Sibutramine versus continuous positive airway pressure in obese obstructive sleep apnoea patients Source: Eur Respir J 2009; 34: 694 Year: 2009 A method for performing double blind sham continuous positive airway pressure (nCPAP) studies in sleep apnea patients Source: Eur Respir J 2002; 20: Suppl. 38, 102s Year: 2002 Twenty years compliance with continuous positive air pressure treatment in patients with severe obstructive sleep apnea Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects Year: 2019 The influence of 3-weeks‘ therapy of continous positive airway pressure (CPAP) on serum leptin and homocysteine concentration in patients with obstructive sleep apnea (OSA) Source: Annual Congress 2005 - Metabolic control in OSA Year: 2005 Comparative study of a novel positive airway pressure therapy versus conventional AutoCPAP therapy in obstructive sleep apnea syndrome (OSA) Source: Eur Respir J 2005; 26: Suppl. 49, 112s Year: 2005